How have CMRA shares performed in 2024?

Comera Life Sciences' stock was trading at $0.0550 at the beginning of 2024. Since then, CMRA stock has decreased by 25.5% and is now trading at $0.0410. View the best growth stocks for 2024 here .

How do I buy shares of Comera Life Sciences?

Shares of CMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NASDAQ:CMRA

Comera Life Sciences (CMRA) Stock Price, News & Analysis

→ Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad)

Free CMRA Stock Alerts

$0.04

-0.02 (-32.79%)

(As of 04/17/2024 ET)

Compare

Today's Range: $0.04
▼
$0.05
50-Day Range: $0.03
▼
$0.06
52-Week Range: $0.03
▼
$0.87

Volume: 2,000 shs
Average Volume: 21,414 shs
Market Capitalization: $1.26 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

Get Comera Life Sciences alerts:

Ad DTI

Start loving Mondays like this

Wouldn’t you love to start looking forward to Mondays? We’re in a New Paradigm Shift in the market that could make it possible! You see, rallies over the weekends have become much more common in the last few years. Imagine hitting a few buttons on your phone or laptop to place a quick trade before the weekend hits… And coming back on Monday to what could be extra income sitting in your account… Weekend after weekend!

Weekend after weekend!

About Comera Life Sciences Stock (NASDAQ:CMRA)

Comera Life Sciences Holdings, Inc., a preclinical stage life sciences company, develops an internal portfolio of proprietary therapeutics that incorporate its proprietary formulation platform. Its SQore platform is designed to enable the conversion of intravenous biologics to subcutaneous versions. The company's lead pipeline candidate is CLS-001, a subcutaneous formulation of vedolizumab for the treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis. Comera Life Sciences Holdings, Inc. was founded in 2014 and is headquartered in Woburn, Massachusetts.

CMRA Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CMRA Stock News Headlines

January 31, 2024 | msn.com

Comera Life Sciences Announces Sweeping Workforce Termination

January 4, 2024 | finance.yahoo.com

Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option

April 17, 2024 | Tips4Traders (Ad)

Uncover this 2024 Hidden Gem

Exclusive Report: Uncover a Hidden Investment Gem We’re excited to share a special report on one exceptional, publicly traded company. This company has achieved a remarkable 22+% just this year, outperforming the market and revealing the potential for significant gains.

January 4, 2024 | finance.yahoo.com

Comera Life Sciences Announces Bridge Financing and Exercise of Take Private Option

December 6, 2023 | msn.com

Comera Life Sciences to explore strategic alternatives

December 6, 2023 | finance.yahoo.com

Comera Life Sciences Announces Process Exploring Strategic Alternatives

November 26, 2023 | benzinga.com

Comera Life Sciences Stock (NASDAQ:CMRA), Analyst Ratings, Price Targets, Predictions

November 14, 2023 | finance.yahoo.com

Comera Life Sciences Designates Dorothy Clarke to Board of Directors

April 17, 2024 | Tips4Traders (Ad)

Uncover this 2024 Hidden Gem

November 13, 2023 | finance.yahoo.com

Comera Life Sciences Appoints Dorothy Clarke to Board of Directors

November 9, 2023 | msn.com

Comera Life Sciences GAAP EPS of -$0.10, revenue of $0.14M

November 9, 2023 | finance.yahoo.com

Comera Life Sciences Reports Financial Results for Third Quarter 2023 and Recent Business Highlights

October 18, 2023 | finance.yahoo.com

Comera Life Sciences Advancing Subcutaneous Monoclonal Antibody Formulations

October 16, 2023 | finance.yahoo.com

Comera Life Sciences Presents SQore™ Platform Technology Data at PODD: Partnerships in Drug Delivery Conference

September 13, 2023 | benzinga.com

Massive Insider Trade At Comera Life Sciences

September 12, 2023 | benzinga.com

10% Owner At This Health Care Company Buys $1.05M of Stock

September 12, 2023 | finance.yahoo.com

Comera Life Sciences Announces the Completion of $4.1 Million Private Placement

August 16, 2023 | finance.yahoo.com

Comera Study Shows Caffeine’s Ability to Reduce Viscosity in Antibodies

August 16, 2023 | finance.yahoo.com

Comera Life Sciences Announces Publication of Study Reinforcing Caffeine’s Viscosity Reducing Capabilities

August 10, 2023 | finance.yahoo.com

Comera Life Sciences Reports Financial Results for Second Quarter 2023 and Recent Business Highlights

August 8, 2023 | finance.yahoo.com

Comera Life Sciences Boosts SQore Platform Patents

August 8, 2023 | finance.yahoo.com

Comera Life Sciences Significantly Expands Intellectual Property Portfolio Strengthening the Proprietary SQore™ Platform

August 2, 2023 | finance.yahoo.com

Comera Life Sciences Announces $4.1 Million Private Placement

August 1, 2023 | finance.yahoo.com

Comera Life Sciences Announces $4.1 Million Private Placement

July 24, 2023 | finance.yahoo.com

Comera Partners with Quality Chemical Laboratories to Strengthen Supply Chain

July 15, 2023 | seekingalpha.com

CMRA Comera Life Sciences Holdings, Inc.

May 11, 2023 | finance.yahoo.com

Comera Life Sciences Reports Financial Results for First Quarter 2023 and Recent Business Highlights

See More Headlines

Receive CMRA Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Comera Life Sciences and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Today: 4/17/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Medical
Industry: Pharmaceutical preparations
Sub-Industry: N/A
Current Symbol: NASDAQ:CMRA
CUSIP: N/A
CIK: 1907685
Web: comeralifesciences.com
Phone: 617-871-2101
Fax: N/A
Employees: 12
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): ($0.49)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-18,000,000.00
Net Margins: -904.00%
Pretax Margin: -901.00%
Return on Equity: N/A
Return on Assets: -297.91%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 0.90
Quick Ratio: 0.90

Sales & Book Value

Annual Sales: $630,000.00
Price / Sales: 2.00
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.37) per share
Price / Book: -0.11

Miscellaneous

Outstanding Shares: 30,740,000
Free Float: 28,002,000
Market Cap: $1.26 million
Optionable: Not Optionable
Beta: 0.37

Elon Musk's Next Move

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report

Key Executives

Mr. Michael G. Campbell CPA (Age 55)
CEO, CFO & Principal Accounting Officer
Comp: $269.11k
Dr. David Soane Ph.D.
Co-Founder & Member of Scientific Advisory Board
Ms. Janice Marie McCourt B.S. (Age 62)
CLP, M.B.A., R.Ph., Chief Business Officer

Key Competitors

View All Competitors

Insiders

View All Insider Transactions

CMRA Stock Analysis - Frequently Asked Questions

How have CMRA shares performed in 2024?: Comera Life Sciences' stock was trading at $0.0550 at the beginning of 2024. Since then, CMRA stock has decreased by 25.5% and is now trading at $0.0410.
View the best growth stocks for 2024 here.
How do I buy shares of Comera Life Sciences?: Shares of CMRA stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:CMRA) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial